Revco was on the verge of getting a higher bid.
Sources familiar with the bidding for the Ohio drugstore chain operator said a management group was planning to sweeten its offer for a leveraged buyout. Wall Street speculation has suggested a price of about $38 a share for the company, or about $1.27 billion. Last March, the group offered $33 a share, an amount that a special panel of outside directors said was too low.
Start your day right
Sign up for Essential California for news, features and recommendations from the L.A. Times and beyond in your inbox six days a week.
You may occasionally receive promotional content from the Los Angeles Times.
